Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Identification and characterization of a novel Enterococcus bacteriophage with potential to ameliorate murine colitis


Increase of the enteric bacteriophages (phage), components of the enteric virome, has been associated with the development of inflammatory bowel diseases. However, little is known about how a given phage contributes to the regulation of intestinal inflammation. In this study, we isolated a new phage associated with Enterococcus gallinarum, named phiEG37k, the level of which was increased in C57BL/6 mice with colitis development. We found that, irrespective of the state of inflammation, over 95% of the E. gallinarum population in the mice contained phiEG37k prophage within their genome and the phiEG37k titers were proportional to that of E. gallinarum in the gut. To explore whether phiEG37k impacts intestinal homeostasis and/or inflammation, we generated mice colonized either with E. gallinarum with or without the prophage phiEG37k. We found that the mice colonized with the bacteria with phiEG37k produced more Mucin 2 (MUC2) that serves to protect the intestinal epithelium, as compared to those colonized with the phage-free bacteria. Consistently, the former mice were less sensitive to experimental colitis than the latter mice. These results suggest that the newly isolated phage has the potential to protect the host by strengthening mucosal integrity. Our study may have clinical implication in further understanding of how bacteriophages contribute to the gut homeostasis and pathogenesis.


The gut microbiota is composed of hundreds of trillions of bacteria, fungi and viruses. In addition to supporting nutrient metabolism, recent studies have shown that commensal bacteria and, to some extent, fungi contribute to intestinal tissue homeostasis and maturation of the immune system1,2. On the other hand, roles of commensal viruses remain largely elusive. Most gut commensal viruses are bacteriophages (hereafter, phages), which infect bacteria. It has been speculated that the human gut is colonized with 109–1010 phage particles per gram of feces, which is the largest group behind bacteria3,4. Therefore, it is likely that as yet unrecognized mechanisms of interaction operate between mammals and phages in the gut in health and diseases. In this context, numerous reports have pointed to the involvement of phages in intestinal pathogenesis5,6,7,8, however, little is known about the role of individual phage in either protective or harmful response.

Recent advances in high throughput metagenomic sequence technology have allowed us to more deeply investigate the complexity and richness of gut phage populations, the phageome4,9,10. In fact, a close link between an increase in gut phage richness and inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis, which was accompanied by a decrease of the diversity of the bacterial populations has been demonstrated8. However, unlike the microbiome and mycobiome (fungi microbiome), the technology of analyzing the phageome is underdeveloped for several reasons. One of them is that many phages have two life cycles, a lytic cycle and lysogenic cycle. In contrast to the former in which host cell infection and lyses for viral dissemination is mediated by packaged, lytic virus-like particles (VLP), the latter cycle is defined by phage genome integration into target bacterial DNA or exosomal cytoplasmic plasmid in microbial host cells11. Although a recent increase in sequencing power has allowed for identification of many temperate phages, it is still difficult to understand the dynamics of changes in their life cycles, during which the phage exerts direct effects on host bacteria and possibly on the gut ecosystem. Additionally, databases for the phage sequences currently cover only around 20% of the sequences identified as phages9.

Enterococcus is a common member of intestinal microbiota and is present across a wide range of taxa, from insects to humans12. Though not inherently virulent, their properties give them a selective advantage in diverse environments. As a result, they out-compete other species when antibiotics are over-used or the host is immunocompromised12. Overgrowth of Enterococcus may potentially lead to their translocation into the host tissue, causing gut abscess, bacteremia and endocarditis. Enterococcus species are more enriched in the gut of IBD patients and treatments with biologics were shown to reduce their abundance13,14. Several recent papers have shown that Enterococcus-related phages also increased during colitis in humans as well as mice5,8. However, the roles of these Enterococcus-related phages in the disease are poorly understood.

In this study, we isolated phages from mouse intestinal content. Using autologous fecal Enterococcal bacteria, we screened for VLPs by phage plaque assay. A novel phage, termed phiEG37k was then identified by its association with Enterococcus gallinarum, whose frequency was found to be increased in mouse experimental colitis models. We then characterized the phiEG37k infectivity against the host and identified the life cycle within the intestinal ecosystem. Furthermore, by inducing colitis in the mice colonized with phiEG37k together with its host bacteria, we demonstrate the enhancement of colonic MUC2 by the phage and its ameliorating effect on colitis. We discuss these findings in the context of how bacteriophages contribute to gut homeostasis and pathogenesis.


Screening of intestinal phage by plaque assay

To isolate intestinal resident phages, we conducted a plaque assay using VLP fraction from the feces of C57BL/6 mice with individually isolated bacterial clones from the same mice (Fig. 1a). Since Enterococcus phage levels are notably increased in mouse colitis and human IBD5,8, we aimed at isolating Enterococcus-associated phages, which may affect the disease development. Sixteen of 125 fecal Enterococcus bacterial clones from six mice consequently were sensitive to infection by fecal VLP. Eleven of the 16 bacterial colonies showed an increase in the numbers of their related phages in the feces during dextran sulfate sodium (DSS)-induced colitis (Fig. 1b). Most notably, a phage related with one of the Enterococcus bacterial strains (G0) displayed a thousand-fold increase, with the highest increasing rate during colitis (Fig. 1b and Supplementary Fig. S1 online). After confirming the reproducibility of the increase of the G0 strain-related phage during the DSS-induced colitis, we decided to further investigate the role of this phage in this disease model.

Figure 1

Identification of novel Enterococcus phages associated with colitis. Colitis-associated Enterococcus phages were identified by screening feces from C57BL/6 mice using a plaque assay. (a) Schema of screening for gut Enterococcus phages from C57BL/6 mice in steady state. (b) Plaque-forming unit (PFU) of phages associated with 16 individual Enterococcal bacterial clones was measured in steady state (SS) and during dextran sulfate (DSS)-induced colitis. The feces during colitis was taken on day 10, which is 3 days after the replacement of DSS with normal drinking water. The PFUs of the phage associated with Enterococcus strain G0 (phiEG37k) are indicated with black circles. (c) Plaques formed by phiEG37k phage (left panel) and the transmission electron microscopic image of the phage (right panel). (d) Scanning electron microscopic images of interaction of phiEG37k with host E. gallinarum or a resistant strain derived of the original strain. phiEG37k phages attached to the E. gallinarum are indicated by red arrows. Scale bars indicate 1 µm. (e) Electrophoresis of phiEG37k genome DNA on 1% agarose gel. MW; molecular weight marker (f) Lysis curves of E. gallinarum co-cultured with phiEG37k or phiEG-1, or without phage. The OD660 was measured on indicated time points. (g) Adsorption assay of phiEG37k and phiEG-1.

Characterization of the isolated phage and its host

We then isolated the G0-associated phage which shows 1000-fold increase in colitis (Fig. 1b and Supplementary Fig. S1 online) and subjected it to electron microscopy analysis. The transmission electron microscope (TEM) analysis revealed that it is a long-tailed phage, which morphologically belongs to the family Siphoviridae in the order Caudovirales and is usually a dsDNA phage (Fig. 1c). The scanning electron microscope (SEM) analysis also revealed that the phage attaches to the surface of host Enterococcus bacteria, whereas it failed to attach to a phage-resistant mutant generated from the original host strain G0 (Fig. 1d). The genome size of the phage was found to be about 37 k bp by Pippen pulse electrophoresis (Fig. 1e and Supplementary Fig. S2 online).

The whole genome sequence analysis revealed that this is a novel phage consisting 37,025 bp (Supplementary Table S1 online). Further, we identified that the host bacterium is E. gallinarum. We then termed this E. gallinarum-associated phage phiEG37k. The RAST analysis of predicted amino acid sequences based on the genome sequence revealed that phiEG37k possesses phage structural protein genes including major capsid protein, tail protein and tail length tape-measure protein (Supplementary Table S1 online). In addition, we detected the presence of the gene encoding phage lysin N-acetylmuramoyl-L-alanine amidase, an enzyme that hydrolyzes the phage-bacterial cell wall upon release of its progeny. Notably, phiEG37k also possesses an integrase gene, indicating that this phage is a temperate phage (Supplementary Table S1 online). Consistently, we found a gene encoding a RinA family phage transcriptional regulator required for the expression of the morphogenetic and lysis modules of the phage15 (Supplementary Table S1 online).

To further characterize phiEG37k, we next evaluated the lytic and adsorption activities of the phage. The lysis curve showed that phiEG37k only partially lysed the host bacteria and reached equilibrium between host growth and lysis in liquid culture within 4 h of coincubation of the phiEG37k and E. gallinarum (Fig. 1f). In contrast, phiEG-1, another E. gallinarum-related phage isolated from sewage, has strong lytic ability and completely killed the host. The adsorption ability of phiEG37k on the host is about 25% lower than that of phiEG-1 (Fig. 1g). These results suggest that the phiEG37k phage and its host bacteria are capable of stably coexisting with each other in the gut ecosystem.

Abundance of phiEG37k in colitis in mice

We next examined the potential role of phiEG37k in intestinal pathogenesis. In parallel with an increase in the number of phiEG37k during DSS-induced colitis in mice, the numbers of E. gallinarm were increased with the development of colitis (Fig. 2a). The correlation coefficient 0.8573 showed strong positive linear relationships between the phage and E. gallinarm titers both in the steady state and during DSS colitis development (Fig. 2b). The phage to microbe ratio (PMR) is about 1:1,000 which is considerably low (Fig. 2b). In general, phages prefer a lysogenic life cycle over a lytic cycle so as to take advantage of the bacterial proliferation in order to effectively propagate themselves in many ecosystems16. We then attempted to isolate 50 different colonies of E. gallinarum from the feces of C57BL/6 mice in steady state as well as after the onset of DSS colitis and subjected them to PCR analysis for the phiEG37k genome. Consistent with the above view, the phiEG37k genome was amplified in 44 of 50 colonies in steady state and in all 16 colonies of E. gallinarum after DSS colitis (Fig. 2c and Supplementary Fig. S3 online).

Figure 2

Most phiEG37k phages exist in lysogenic cycle in the colonic ecosystem in SPF C57BL/6 mice. The characterization of the interaction of phiEG37k phage and host E. gallinarum in the gut ecosystem was investigated. (a) Titers of E. gallinarum (left panel) and phiEG37k (right panel) in feces in steady state (SS) or DSS colitis (DSS). (b) Correlation curve of E. gallinarum titer versus phiEG37k titer in feces. n = 10. (c) PCR analyses of picked colonies of E. gallinarum isolated from feces of C57BL/6 mice in steady state by phiEG37k-specific primer. (d) Titer of phiEG37k phage particles in supernatant of individual cultures of different E. gallinarum colonies in c in the absence or presence of mitomycin C. (e) Spot assays of phiEG37k against individual clones in (d). ND; not detected. Two-tailed unpaired t-test P values are presented.

We next compared draft-whole genome sequences between randomly chosen phiEG37k-containing E. gallinarum strains, G2, G3, G4 and G6 (see Fig. 2c), with the original strain G0 (phiEG37k-free) and confirmed that the phage sequence was integrated at the same site in the genome of all four strains (Supplementary Fig. S4 online). We performed phylogenetic analysis of G0 and the four lysogenic strains (G2, G3, G4 and G6) with a type strain E. gallinarum NCTC12359 (accession no. GCA_900447935.1) based on single nucleotide polymorphisms (SNPs) in the core-genome that is defined as DNA regions of genome shared by these compared strains. It revealed that G0 and all the lysogenic strains formed a cluster with sharing 81.6% of the core-genome of NCTC 12359 (2,910,014/3,564,437 bp, Supplementary Fig. S5a online). As shown by the radial phylogenetic tree (Supplementary Fig. S5b online), the core-genome of the four lysogenic strains was 100.0% (3,563,364/3,564,437 bp) shared with G0, with the number of SNPs ranging from 30 to 69 between neighboring strains without shared SNPs, indicating that these strains divided from a common ancestor, which have not been isolated in this study17 (Supplementary Fig. S5b, c online).

As expected, all of the above and some additional lysogenic E. gallinarum strains (G2, G3, G4, G5, G6, G8 and G9) were able to produce the lytic phage in liquid culture, the levels of which are dramatically augmented by mitomycin C treatment which induces a lytic phage release (Fig. 2d). Given that the PMR remained low and most fecal E. gallinarum bear lysogenic phiEG37k, most phiEG37k phage appear to exist largely in the lysogenic cycle in the mouse gut ecosystem. Of note, all of the E. gallinarum carrying the lysogenic phage displayed resistance to phiEG37k infection (Fig. 2e), supporting the notion that the ratio of lytic phiEG37k to E. gallinarum is relatively stable in the gut.

Evaluation of the impact of phiEG37k colonization on intestinal homeostasis

To explore how gut colonization of E. gallinarum infected by phiEG37k affects the host’s intestinal pathogenesis, we first attempted to generate mice colonized with the host bacteria alone (G0 strain) or mice colonized with the G2 strain which is a lysogeny strain containing phiEG37k genome by oral gavage. First, C57BL/6 mice were purchased from one of the mouse suppliers whose mouse colonies are free from phiEG37k (Supplementary Fig. S6 online). However, the colonization of both strains (G0 and G2) turned out unsuccessful; this is probably due to colonizing resistance caused by the resident microbiota18. Therefore, as an alternative approach, we chose mice colonized with Altered Shaedler Flora (ASF) consisting of eight known symbiotic commensal bacterial species but without Enterococcus bacteria (hereafter ASF mice)19. We then found that both the phage-free E. gallinarum G0 and the phiEG37k-positive E. gallinarum G2 were stably colonized for longer than 4 weeks after inoculation by oral gavage to these mice (Fig. 3a, b).

Figure 3

Stable colonization of E. gallinarum bearing lysogenic phiEG37k phage produces residual phage particles in the colon. C57BL/6 mice that have Altered Shaedler Flora (ASF-mice) were gavaged E. gallinarum either free from (G0 strain) or bearing lysogenic phiEG37k (G2 strain). (a and b) Titers of E. gallinarum (a) and phiEG37k (b) in feces from the ASF mice with no Enterococcus colonization (Ctrl), G0-colonization or G2-colonization at 4 weeks post-gavage. (c) Components of colonic microbiota in mice of the three groups described in (a). (d) Abundancy of individual bacteria consisting of ASF or E. gallinarum in the colon from mice described in (a) was displayed. One way analysis of variance with Tukey’s multiple comparison was performed for ad-hoc analysis. ns; not significant. n = 6–7.

In further characterization of these ASF mice with E. gallinarum, we confirmed by whole genome sequencing analysis that G0 and G2 strains had only 60 single nucleotide polymorphisms on the core-genome (Supplementary Table S2 online). Enterococcus titers were equivalent in the feces between the two mouse strains (Fig. 3a). There was no significant alteration in abundance of the eight individual bacterial components of ASF between the mice colonized with G0 and G2 strains in steady state, although there was a slight decrease in that of E. gallinarum in the G2-coloinized mice (Fig. 3c, d). The components of ASF as well as E. gallinarum were not altered significantly during colitis between the mice colonized with G0 and G2 strains (Supplementary Fig. S7 online).

To explore how the immune cell phenotype is influenced by gut colonization with E. gallinarum with or without phiEG37k phage, i.e., G2 and G0 strain, flow cytometric analysis was performed for T cells and dendritic cells from lamina propria. There was no observed significant difference in cell frequencies or expression of activation markers between the mice colonized with G0 and G2 strains (Supplementary Fig. S8 online). Interestingly, however, comparative analysis for gene expression profiles of whole colon tissues between these mice revealed that thirty-four genes were significantly changed in the mice colonized with G2 strains, i.e. phiEG37k-colonized mice (Supplementary Fig. S9 and Table S3 online). Interestingly, mRNAs for a series of mucin genes including Muc2, Muc3, Muc3a and Muc4 were significantly elevated in the colons from the phiEG37k-colonized mice as compared to those from uncolonized mice (Supplementary Fig. S9 and Table S3 online).

Mucin proteins are major components of mucus, which physically covers the surface of intestinal epithelial cells to protect from invasion of commensal or pathogenic bacteria20,21,22. In fact, immunohistochemical analysis revealed an elevation of MUC2 production in the colonic epithelial cells from phiEG37k -colonized mice compared with those from uncolonized mice (Fig. 4a). Thus, these results suggest that the phiEG37k colonization potentially enhances the barrier of intestinal mucosa through higher levels of MUC2 production.

Figure 4

Enterococcus phage colonization potentially enforces colonic barrier function. The role of phiEG37k in gut homeostasis and inflammation was explored by analyzing the ASF-mice colonized with G0 or G2. (a) Immunohistochemical analysis for MUC2 protein in the colonic tissue from ASF-mice colonized with G0 or G2 (n = 3 per each group). Representative images of lower colons from mice colonized with G0 or G2 (left panel). The percentage of MUC2-stained area in mucosal area (right panels) was quantitated by ImageJ software. Scale bars indicate 500 µm in left panels and 100 µm in right panels. (bd) 2.5% of DSS was administered for 7 days to G0- or G2-colonized mice for colitis induction (n = 4–7 per each group). Two independent experiments were performed. (b) Body weight change during DSS colitis (n = 5 for G0, n = 4 for G2). (c) Colon length on day 9 post-administration with DSS is shown. (d) Representative HE stained colonic tissue (left panels) and histology scores of colitis (right panel) from mice described in (b). Scale bars indicate 500 µm. Two-tailed unpaired t-test P values are presented. ns; not significant. n = 3 in (a). n = 4–5 in (c) and (d).

As an approach to explore whether G2 or phiEG37k directly enhances mucin genes, we incubated the human colonic epithelial cell line Caco-2 with E. gallinarum G0, lysogenized strain G2 or phiEG37k. However, MUC3 mRNA expression was not significantly elevated in Caco-2 cells co-cultured with G2 or phiEG37k compared to that with G0 (Supplementary Fig. S10 online). Caco-2 cells lack the MUC2 gene and the MUC4 mRNA level was too low to quantify expression levels. Although the result is seemingly inconsistent with that in G2-colonized mice, we infer that the environment of gut lumen and mucin in vivo cannot be reproduced in vitro. In the gut mucosa, more intensive bacterial lysis may occur by phage infection or by a life cycle switch from lysogenic to lytic, which leads to exposure of bacterial antigens and/or pathogen-associated molecular pattern molecules to the gut epithelial and dendritic cells. Alternatively, it may be ascribed to the difference between cell lines and primary cells, or difference between cells from human and mice in terms of the cell’s responsiveness to the phage. Finally, we cannot exclude the possibility that the mRNA induction in vivo by phiEG37k may be indirect in that yet unknown factors may be mediating the mRNA induction by the phage. This is obviously in interesting issue to be addressed in the future study.

Effect of the phiEG37k-containing bacteria in colitis

We next examined the ASF mice with or without the phage colonization in DSS-induced colitis model. Both mice colonized with G0 and the phage-containing G2 strains were healthy and had no signs of colitis at least 4 weeks post-colonization. These mice were then treated with 2.5% of DSS. The symptoms of DSS-induced colitis are characterized by body weight loss and bloody diarrhea. Although no significant difference in body weight changes was detected between the colonized mice of the G0 strain and G2 strain (Fig. 4b), we observed significant differences in colon length after 9 days post-induction of colitis. The G2 strain-colonized mice displayed longer colons than uncolonized mice, indicating that inflammatory changes in the colon tissue, such as infiltration or edema, are ameliorated by the G2 strain colonization (Fig. 4c). Further, histological analysis revealed a broader area of colonic mucosa was inflamed in G0 strain-colonized mice than in G2 strain-colonized mice (Fig. 4d, left), Histology scores were substantially lower for the G2 strain-colonized mice compared to those of the G0 strain-colonized mice (Fig. 4d, right). Taken together, phiEG37k-containing G2 strain colonization displayed a mild ameliorating effect on DSS-induced colitis. This effect may be attributed to the enhanced production of MUC2 by colonization with G2.


In this study, we isolated and characterized a novel gut-resident phage phiEG37k and its host E. gallinarum by screening based on lytic activity of the VLP fraction of feces from C57BL/6 mice. We found that the lytic phiEG37k resides as phage particles in the gut across C57BL/6 mice. Both gut E. gallinarum and phiEG37k phage were increased during colitis, and their titers had a strong correlation with very low PMR across the mice in steady state as well as during colitis. We also found that a majority of intestinal E. gallinarum in C57BL/6 mice bore lysogenic phiEG37k in their host genome, which also displayed resistance to phiEG37k infection. These results suggest that a small fraction of host lysogens release phiEG37k phage particles due to the change of their life cycle from lysogenic to lytic state.

We successfully generated mice colonized with the host E. gallinarum with the lysogenic phiEG37k phage (G2 strain) and without the prophage (G0 strain). The G2-colonized mice stably displayed the phiEG37k lytic phage in the gut. Furthermore, we found that these mice are more resistant to experimental colitis, compared to the G0 -colonized mice, suggesting the ameliorating effect of phiEG37k on colitis. The enhancement of MUC2 production in the colonic epithelial cells from phiEG37k-colonized mice (Fig. 4a) may account for the ameliorating effect of the phiEG37k phage in this colitis model.

Our study elucidated a mechanism for increased phage particles during colitis that occurred as a result of an increase in the number of host lysogens releasing lytic phage in the gut. Few studies have focused on intestinal resident phage from the point of view of the different life cycles of the phage and its interaction with the host bacteria in the gut ecosystem. Very recent progress of metagenomic analysis has allowed us to characterize host-phage relationships beyond information about diversity and abundance of bacteriophage populations6,23,24. However, we have not been able to trace their life cycle changes or interactions with host bacteria. In this regard, our study could provide new findings about the biology of gut phage.

The lower value of PMR indicates low production of phage particles and suggests that the phage is in the state of lysogeny25. The PMR of phiEG37k to E. gallinarum ≈ 0.01 is much lower than that observed in the sea and soil where lytic phage is dominant, 2.6 to 16024. This suggests that most phiEG37k phage resides in the lysogenic cycle and a very small fraction of the phiEG37k switches from the lysogenic to the lytic cycle resulting in the release of phage particles from host cells. It is also speculated that host E. gallinarum is comprised of a mixed population of dominant lysogens bearing φEG37k prophage with very few prophage-free cells in the mouse gut25.

Host bacteria that were once infected with certain phages, become resistant to the phage through multiple mechanisms26. A majority of E. gallinarum colonies in the feces from C57BL/6 mice were observed to bear prophage phiEG37k, indicating that they had been previously infected with phiEG37k (Fig. 2c). It has been hypothesized that host bacteria killed by gut residual phage contributes to the maintenance of microbiota composition by inhibiting excessive expansion of certain host bacteria, however, this is not the case for certain bacteria that are lysogens and resistant to the infection by the related phage as E. gallinarum lysogen is resistant to phiEG37k (Fig. 2e).

It is interesting that mice colonized by phiEG37k phages are more resistant to DSS-induced colitis (Fig. 4b). This result suggested an increase in lytic phiEG37k phage particles was not disease initiating, but the consequence of gut inflammation under which E. gallinarum robustly expanded. Multiple different phages increase in the gut during gut inflammation in mice as well as in humans5,8. Thus, we speculate the real impact of the phageome on colitis could be a consequence of the accumulation of a variety of effects by multiple phages. Some phages could have colitogenic effects in colitis, while others have a role as exemplified in this study with phiEG37k, which is involved in the enhanced production of MUC2. In this regard, adherent invasive Escherichia coli–related phages, which directly stimulate immune cells resulting in exacerbation of colitis, might be an example as shown in a recent paper7.

Another interesting question not answered by our study is how phiEG37k functions in the production of MUC2. Since the expression of MUC2 proteins and mRNA are enhanced in the phiEG37k-colonized colon, epithelium cells might have continuously received signaling from altered mucus environments generated by phiEG37k colonization. Another possibility is that the phiEG37k phage particles engulfed by dendritic cells in the lamina propria may have indirectly stimulated epithelial cells to enhance mucin production, as shown in the recent study7. It is also possible that the phiEG37k phage particles might localize on the surface of the mucus layer, as previously reported27. In this report, a “bacteriophage adherence to mucus” model was proposed in that phages have an immunoglobulin (Ig)-like structure in the tail and loosely bind to the surface of mucus through this structure which limits the number of intestinal bacteria able to penetrate the mucus layer. Thus, following this model, the lytic phiEG37k phage might be concentrated on the mucus surface and lysed host bacterial cells, leading to the alteration of mucus components of the cell fragments, including bacterial cell walls and DNA. Further study is obviously required to clarify this point.

We here propose the scenario that phiEG37k prophage-bearing G2 enforces mucin production and alleviates murine colitis. However, since G0 and G2 are genetically 100.0% identical except for the insertion of phi37kEG genome and have nonsynonymous SNPs between them (Supplementary Table S2 online), we cannot rigorously exclude the possibility that the difference in E. gallinarum strain-specific characteristics might result in different sensitivity to colitis. Further study will be required to impeccably clarify this issue.

In summary, we identified an E. gallinarum-associated novel temperate phage, phiEG37k, which is colonized in the mouse gut and increases with experimental colitis, and adduced evidence for its potential to protect the host from colitis. Exact mechanism(s) of how this phage actually contributes to the pathogenesis needs further investigation. In view of a close link between phage abundance and IBD5,8, one may speculate from our study that there may be distinct phage populations in IBD that affect either for disease exacerbation or suppression. If so, one could isolate protective phages and host bacteria for the disease amelioration and/or suppression. Such an effort may pave a way for a new rationale for phage therapy of the disease.

Materials and methods


Specific pathogen free C57BL/6 mice (n = 41) were purchased from Clea Japan, Inc or Charles River Laboratories Japan (n = 29). The screening of gut phage was conducted using C57BL/6 mice from Clea Japan. The feces for detection of phiEG37k phage was obtained within a week after the mice had shipped from the vendors. Germ-free C57BL/6 mice purchased from Clea Japan were colonized with Alter Schaedler flora (ASF mice) and maintained in vinyl-isolators at Central Institute of Experimental Animal (CIEA, n = 73). All animal experimental protocols under SPF condition were approved by the Institutional Animal Care and Use Committees of the University of Tokyo (Approval numbers:27-8 and RAC19003). Experiments using ASF-colonized mice were approved by the Institutional Animal Care and Use Committees of CIEA (Approval number: 19062A). All animal care and experiments were performed in accordance with guidelines of the University of Tokyo and those of CIEA. The experiments involving live animals were done by following the recommendation in the ARRIVE guidelines.

Dextran sodium sulfate (DSS)-induced colitis

For colitis induction in SPF C57BL/6J mice, the mice were administered with 2.0% DSS (MP Biomedicals) in drinking water ad libitum for 7 days. Regarding the screening experiments, feces was taken 3 days after the administration of DSS was stopped. For ASF mice colonized with E. gallinarum, the mice were administered with 2.5% DSS in drinking water for 7–9 days 4 weeks after gavage with the bacteria. For body weight (BW) change studies, percent BW relative to that at day 0 was determined.

Preparation of Enterococcus host strains and phage source

We conducted screening for feces from 16 mice. One to two feces taken from individual C57BL/6 mice were pooled and suspended in SM buffer (100 mM NaCl/8 mM MgSO4/50 mM Tris–HCl/0.01% gelatin, pH7.5) at 0.025 mg/ml or 0.05 mg/ml. To obtain Enterococcus bacterial colonies, 100 µl was inoculated on BBL Enterococcus agar (BD) plate and cultured at 37 °C overnight. The colonies were picked next day and transferred in 100 µl of Luria–Bertani (LB) medium for culture overnight. On the third day, glycerol stocks of individual Enterococcus bacteria were generated and stored at − 80 °C. To obtain VLP, the supernatant of the remaining fecal suspension was collected by centrifuging at 8000 × g for 5 min and added with 10 µl of chloroform on the first day. The VLP suspension from individual mice was pooled and kept at 4 °C until used for assays. The overnight culture of individual Enterococcus bacteria from the glycerol stock and the VLP were submitted to plaque assays. To prepare VLP suspension from mice with colitis, colonic content obtained by cutting open the colon was suspended in SM buffer. To confirm the alteration in abundance of fecal VLP in colitis, the sixteen Enterococcus bacterial clones that were sensitive to fecal VLP infection at the first screening plaque assay were subjected to another set of plaque assays with VLP suspension obtained from another set of 10 mice in steady state and with DSS colitis.

Plaque assays

For the screening, fifty or 100 µl of VLP was mixed with 100 µl of overnight culture from individual glycerol stocks of Enterococcus bacteria and then added in 3 ml of 45 °C-warmed LB soft agar (0.5% agar) and vortexed. The mixture was transferred to a petri dish and cultured at 37 °C. The number of plaques was counted the next day. For evaluation of titer of fecal phiEG37k-colonization in ASF mice, a piece of feces (0.01 to 0.035 g) was suspended in 1 ml of SM buffer and 10 µl of fecal VLP was mixed with 100 µl of overnight culture from glycerol Enterococcus gallinarum (G0 strain) for the plaque assay as described.

Isolation and purification of phiEG37k

The phiEG37k was isolated from a single plaque formed at the plaque assay described above. The plaque together with host bacteria in the soft agar was inoculated in 2 ml of LB media buffered with SM buffer (LB/SM media) overnight. The small culture was transferred to the large volume culture in LB/SM media containing freshly cultured E. gallinarum suspension and cultured overnight. The next day the cell suspension was centrifuged at 8000 × g for 5 min and one drop of chloroform was added to the collected supernatant. Gradient precipitation by CsCl (1.46, 1.55 and 1.63 g/ml) was conducted to isolate a large number of phage particles. To exchange the buffer, dialysis was performed with SM buffer.

Transmission electron microscope (TEM) analysis for the phage

Purified phages diluted in PBS were allowed to adhere to 300-mesh carbon-coated Cu grids (Veco grids; Nisshin EM, Tokyo) for 1 min at room temperature, and then negatively stained with 2% uranyl acetate solution. TEM analysis was performed using H-7650 (HITACHI, Tokyo, Japan).

Scanning electron microscope (SEM) analysis

Enterococcus gallinarum were infected with 10 multiplicity of infection (MOI) of phiEG37k for the indicated time periods in LB media and fixed with 2% paraformaldehyde and 2.5% glutaraldehyde in PBS, followed by post fixation with 1% OsO4 in the same buffer. The fixed samples, which were placed on poly-L-lysine-coated coverslips, were washed three times with PBS, dehydrated in graded acetone solutions (50, 70, 90, 95, 99.5%), and then immersed in tert-butyl alcohol. After replacing the ethanol with tert-butyl alcohol, the samples were dried by using a freeze-drying device (VFD-21S; VACUUM DEVICE), and then coated with osmium by using a plasma coating device (Neoc; Meiwafosis). The samples were visualized with SEM (SU6600, Hitachi High-Technologies, Tokyo, Japan).

Genome isolation and whole genome sequence for the phiEG37k and host Enterococcal bacteria

The genome of phages was extracted by PureLink Viral RNA/DNA Mini Kit (Invitrogen) by following the manufactural protocol. Bacterial genome was isolated by DNeasy Blood & Tissue (QIAGEN) by following the manufactural protocol. The whole genome sequence of purified phage and bacteria was analyzed by next generation sequencer (HiSeq, Illumina) with 150 bp paired-end sequencing at BGI genomics and Eurofins genomics, respectively. All sequenced data for the phage were assembled by SPAdes ( The individual genes in the whole phage genome of phiEG37k (accession number; LC625742) were annotated by RAST server ( The host bacterium was identified as E. gallinarum by the Average Nucleotide Identity (ANI) analysis using draft whole-genome sequencing data.

Core-genome single polymorphism analysis

To analyze the core-genome single-nucleotide polymorphism (SNP)-based genetic relationship among E. gallinarum strains, HiSeq sequencing data were aligned to the complete genome sequence of E. gallinarum G0 draft genome using Burrows-Wheeler Aligner with the “MEM” option. SNP extraction was performed by SAMtools (version 1.1) mpileup and VarScan (version 2.3.7) mpileup2cns.

Coculture of phiEG37k and E. gallinarum

Twenty µl of fresh confluent G0 and 20 µl of 4 × 106 phiEG37k particles were mixed to allow the phage adsorption on the host G0. To remove the unabsorbed phages, the mix was centrifuged at 8000 × g for 5 min and the supernatant was discarded. After washing twice, the host cell pellet resuspended in 4 ml LB was transferred to an L-shaped glass test tube and culture was started. For lytic curves, the optical density at wavelength of 660 nm (OD660) was monitored by TVS062CA a compact rocking incubator (Advantec, Tokyo, Japan) at 20-min intervals for a minimum of 9 h following phage addition. In some experiments, 0.5 µg/ml of mytomicin C was added to the bacterial culture to induce a curing of all lysogenic phage from the host cell.

Adsorption assay

Adsorption efficiency of the phiEG37k on E. gallinarum was measured by titrating the presence of free phages in the supernatant under the low MOI condition (MOI = 0.01) for 20 min to evaluate the affinity of initial adsorption between a host cell and its phage.

Determination of fecal titer of phiEG37k and E. gallinarum

One to two pieces taken from SPF C57BL/6 mice were weighed and suspended in 1 ml of SM buffer. One hundred µl or 10 µl of fecal suspension from C57BL/6 mice or ASF mice, respectively, was inoculated on an Enterococcal agar plate and cultured overnight. The next day, ten colonies were picked and subjected to PCR specific to E. gallinarum (see the following PCR methods). The fecal titer of E. gallinarum was calculated based on the number of E. gallinarum-PCR positive colonies. The rest of the fecal suspension was centrifuged at 8000 × g for 5 min and the supernatant was used for the VLP solution. One hundred µl of VLP solution from SPF C57BL/6 mice or ten µl of VLP solution from ASF mice was submitted to a plaque assay with overnight cultured E. gallinarum G0 strain. The fecal titer of phiEG37k was calculated based on the number of plaques by the assay.

PCR for E. gallinarum and phiEG37k

To determine if individual bacterial colonies grown on the Enterococcus plate were E. gallinarum, colony-pick PCR was performed using Mighty Amp Polymerase III (Takara) with primer specific to E. gallinarum. The primer used was forward 5′-TTACTTGCTGATTTTGATTCG-3′; reverse 5′-TGAATTCTTCTTTGAAATCAG-3′. The PCR conditions were as follows; (1) an initial step of 2 min at 98 °C and (2) 32 cycles with a cycle consisting of 30 s at 94 °C, 1 min at 55 °C and 1 min at 72 °C. To determine whether the genome of E. gallinarum bear integrated phiEG37k genome, E. gallinarm colonies were picked and subjected to PCR with primer specific to phiEG37k: forward 5′-TGAGTAACATCAACATGGGCTTAG-3′; reverse 5′-ATATGCCACCTGCTTTCCTG-3′. The PCR conditions were as follows; (1) an initial step of 2 min at 98 °C and (2) 32 cycles with a cycle consisting of 30 s at 94 °C, 1 min at 60 °C and 20 s at 72 °C. The primer amplifies 130 bp size segment of genomic DNA at a site between bp 21,073 and 21,202, containing a 3′-end of BppU family phage baseplate upper protein and a 5′-end of hypothetical protein (Supplementary Fig. S11 online).

Spot assay

Five microliters of phage suspension with indicated titers were dropped onto the LB soft agar plate mixed with 100 µl of overnight culture from glycerol stock of E. gallinarum (G0 or G2 strain). The phage resistance of individual strains of E. gallinarum was assessed by the clarity of plaques, which was scored as clear, turbid or faint.

Colonization of the phiEG37k and E. gallinarum

5 × 108 of either strain of E. gallinarm G0 or G2 was gavaged ASF-colonized C57BL/6 mice at 4 weeks of age. After 4 to 6 weeks, DSS-colitis was induced. To confirm the colonization of the phage and host bacterium, feces was collected before and at indicated time points after E. gallinarum administration and subjected to titer check for phiEG37k and E. gallinarum. The titer of E. gallinarum was determined by PCR as described above. The titer of free phiEG37k phage was determined by plaque assay with E. gallinarum G0 strain.

Microbiota composition of ASF mice

Bacterial DNA was extracted from ASF-mice, and G0- or G2-colonized ASF-mice using QIAamp DNA Stool Mini kit (Qiagen) by following manufactural protocol and submitted to quantitative PCR using primers for each bacterial component of ASF19 and for eubacterial 16S rRNA28. The PCR condition was described previously19.

RNA-seq analysis

Whole colon was dissected from G0- and G2-colonized ASF mice and homogenized by polytron in TRIZOL (Thermo Fisher) after removing feces. Total RNA was extracted by following the manufactural protocol of TRIZOL. 500 ng of total RNA was used for rRNA depletion (New England Biolabs, E6310), followed by directional library synthesis by using Next® Ultra™ Directional RNA Library Prep Kit (NEB E7420). Sequencing was performed by NextSeq500 (Illumina). A paired-end run was conducted to obtain 2 × 36-base reads. FASTQ files were imported to CLC Genomics Workbench (CLC-GW, v10.1.1, Qiagen), mapped to mouse reference genome (mm10), and quantified for 49,585 genes. For statistical analysis, pairwise comparison was conducted with Empirical Analysis of DGE tool in CLC-GW. Differentially expressed genes were determined by a false discovery rate-adjusted P-value of less than 0.05.

Isolation of lamina propria cells

The detailed procedure was previously described29 and is briefly summarized as follows. Whole colonic tissue was incubated in EDTA-containing buffer to remove IEC. The remaining lamina propria with muscles was cut into small pieces and digested with collagenase D (Roche), DNaseI (Roche) and dispase (Roche). After washing, cell suspension was subjected to gradient separation to obtain lamina propria cells in the layer between the upper and lower phase. The antibodies used were listed in Supplementary Table S4 online.

Flow cytometric analysis

Cell surface staining was performed by standard procedures and reagents. Intracellular staining for cytokines and Foxp3 staining was performed using eBioscience™ Foxp3 / Transcription Factor Staining Buffer Set with manufacturer’s protocols (Invitrogen). Dead cells were eliminated in intracellular staining experiments by LIVE/DEAD® Fixable Dead Cell Stain Sampler Kit (Invitrogen). Analysis was performed using LSR Fortessa instrument (BD Biosciences) and FlowJo software (BD Biosciences). All antibodies used in the study are shown in the Supplemental Table S4 online.

Culture of Caco-2 cell line

Caco-2, a human colonic epithelial cell line, was purchased from ATCC. When the cells plated in 24-well plates reached 80% confluence, G0, G2 or phiEG37k was added in the following numbers; G0 or G3, 4 × 103, 2 × 104 and 1 × 105 cells; phiEG37k, 4 × 10, 2 × 102, 1 × 103, 1 × 104 and 1 × 105 phage particles. After 4 h, the supernatant was discarded and 500 µl of RNA iso plus (TAKARA) was added to subject to RNA extraction.


Total RNA from Caco-2 cells was extracted by following the manufactural protocol of RNAiso and reverse-transcribed with PrimeScript™ RT reagent Kit with gDNA Eraser (TAKARA). qRT-PCR was performed on Light Cycler 480 (Roche Bioscience) using the TB Green® Premix Ex Taq™ II (TAKARA) and values were normalized to the expression of GAPDH mRNA. Primer sequences are as follows: GAPDH forward 5′-CCTCCAAGGAGTAAGACCCC-3′; GAPDH reverse 5′-TGTGAGGAGGGGAGATTCAG-3′; MUC3 forward 5′-CAGTCCCCCAGCCCTAAA-3′; MUC3 reverse 5′-TATACCTTGCTAGGGACCAGGA-3′.

Histological analysis

Isolated colons were fixed in 4% paraformaldehyde for 16 h at room temperature, embedded in paraffin and stained with hematoxylin and eosin (H&E). Immunohistochemical analysis of MUC2 was performed with rabbit polyclonal anti-MUC2 Ab (GENETEX, Inc) and HRP-conjugated secondary Ab to visualize signal using DAB substrate. The H&E or immunohistochemical sections were examined by automated fluorescence microscope BX63 (Olympus). Colitis histological scoring was performed by following a previous study30. Each section is assigned for scores based on the degree epithelial damage (None, 0; Loss of less than basal 1/3 of the crypt, 1; Loss of the entire crypt but intact surface epithelial cells, 2; Loss of both the entire crypt and the surface epithelial cells, 3) and inflammatory infiltration (None, 0; into the mucosa, 1; into submucosa, 2; into muscularis/serosa, 3). Each of the four scores multiplied by 1 if the change was focal, 2 if it was patchy, and 3 if it was diffuse, and the sum is considered as colitis histological scores per mouse which ranges 0 to 36.

Statistical analysis

Statistical analyses were performed using Prism ver. 7.0 software (Graphpad Software, San Diego, CA, USA). An unpaired t-test was used for the two-group comparison. A one-way analysis of variance (ANOVA) was used for the three-group comparison and Tukey’s test was used for ad-hoc test. Two-tailed p-values less than 0.05 were considered significant. All data were expressed as the mean ± standard error (SEM).


  1. 1.

    Iliev, I. D. & Leonardi, I. Fungal dysbiosis: Immunity and interactions at mucosal barriers. Nat. Rev. Immunol. 17, 635–646 (2017).

    CAS  Article  Google Scholar 

  2. 2.

    Nishio, J. & Honda, K. Immunoregulation by the gut microbiota. Cell. Mol. Life Sci. 69, 3635–3650 (2012).

    CAS  Article  Google Scholar 

  3. 3.

    Hoyles, L. et al. Characterization of virus-like particles associated with the human faecal and caecal microbiota. Res. Microbiol. 165, 803–812 (2014).

    CAS  Article  Google Scholar 

  4. 4.

    Shkoporov, A. N. & Hill, C. Bacteriophages of the human gut: The “known unknown” of the microbiome. Cell Host Microb. 25, 195–209 (2019).

    CAS  Article  Google Scholar 

  5. 5.

    Duerkop, B. A. et al. Murine colitis reveals a disease-associated bacteriophage community. Nat. Microbiol. 3, 1023–1031 (2018).

    CAS  Article  Google Scholar 

  6. 6.

    Fujimoto, K. et al. Metagenome data on intestinal phage-bacteria associations aids the development of phage therapy against pathobionts. Cell Host Microb. 28, 380–389 e389 (2020).

    CAS  Article  Google Scholar 

  7. 7.

    Gogokhia, L. et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microb. 25, 285–299 e288 (2019).

    CAS  Article  Google Scholar 

  8. 8.

    Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447–460 (2015).

    CAS  Article  Google Scholar 

  9. 9.

    Norman, J. M., Handley, S. A. & Virgin, H. W. Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology 146, 1459–1469 (2014).

    CAS  Article  Google Scholar 

  10. 10.

    Sausset, R. et al. New insights into intestinal phages. Mucosal Immunol. 13, 205–215 (2020).

    CAS  Article  Google Scholar 

  11. 11.

    De Paepe, M. et al. Bacteriophages: An underestimated role in human and animal health?. Front. Cell Infect. Microbiol. 4, 39 (2014).

    Article  Google Scholar 

  12. 12.

    Duerkop, B. A., Palmer, K. L. & Horsburgh, M. J. Enterococcal bacteriophages and genome defense. PMID: 24649501 (2014)

  13. 13.

    Lewis, J. D. et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric crohn’s disease. Cell Host Microb. 18, 489–500 (2015).

    CAS  Article  Google Scholar 

  14. 14.

    Salem, F. et al. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences. United Eur. Gastroenterol. J. 7, 1008–1032 (2019).

    CAS  Article  Google Scholar 

  15. 15.

    Ferrer, M. D. et al. RinA controls phage-mediated packaging and transfer of virulence genes in Gram-positive bacteria. Nucl. Acids Res. 39, 5866–5878 (2011).

    CAS  Article  Google Scholar 

  16. 16.

    Knowles, B. et al. Variability and host density independence in inductions-based estimates of environmental lysogeny. Nat. Microbiol. 2, 17064 (2017).

    CAS  Article  Google Scholar 

  17. 17.

    Moradigaravand, D. et al. Within-host evolution of Enterococcus faecium during longitudinal carriage and transition to bloodstream infection in immunocompromised patients. Genome Med. 9, 119 (2017).

    Article  Google Scholar 

  18. 18.

    Kim, S., Covington, A. & Pamer, E. G. The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens. Immunol. Rev. 279, 90–105 (2017).

    CAS  Article  Google Scholar 

  19. 19.

    Sarma-Rupavtarm, R. B. et al. Spatial distribution and stability of the eight microbial species of the altered Schaedler flora in the mouse gastrointestinal tract. Appl. Environ. Microbiol. 70, 2791–2800 (2004).

    ADS  CAS  Article  Google Scholar 

  20. 20.

    Allen, A., Hutton, D. A. & Pearson, J. P. The MUC2 gene product: A human intestinal mucin. Int. J. Biochem. Cell Biol. 30, 797–801 (1998).

    CAS  Article  Google Scholar 

  21. 21.

    Bergstrom, K. S. et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6, e1000902 (2010).

    Article  Google Scholar 

  22. 22.

    Johansson, M. E. Mucus layers in inflammatory bowel disease. Inflamm. Bowel Dis. 20, 2124–2131 (2014).

    Article  Google Scholar 

  23. 23.

    Dzunkova, M. et al. Defining the human gut host-phage network through single-cell viral tagging. Nat. Microbiol. 4, 2192–2203 (2019).

    Article  Google Scholar 

  24. 24.

    Shkoporov, A. N. et al. The human gut virome is highly diverse, stable, and individual specific. Cell Host Microb. 26, 527–541 e525 (2019).

    CAS  Article  Google Scholar 

  25. 25.

    Kim, M. S. et al. Diversity and abundance of single-stranded DNA viruses in human feces. Appl. Environ. Microbiol. 77, 8062–8070 (2011).

    ADS  CAS  Article  Google Scholar 

  26. 26.

    Howard-Varona, C. et al. Lysogeny in nature: Mechanisms, impact and ecology of temperate phages. ISME J. 11, 1511–1520 (2017).

    Article  Google Scholar 

  27. 27.

    Barr, J. J. et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl. Acad. Sci. U. S. A. 110, 10771–10776 (2013).

    ADS  CAS  Article  Google Scholar 

  28. 28.

    Furet, J. P. et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 68, 351–362 (2009).

    CAS  Article  Google Scholar 

  29. 29.

    Nishio, J. et al. Requirement of full TCR repertoire for regulatory T cells to maintain intestinal homeostasis. Proc. Natl. Acad. Sci. U. S. A. 112, 12770–12775 (2015).

    ADS  CAS  Article  Google Scholar 

  30. 30.

    Chassaing, B., Aitken, J. D., Malleshappa, M. & Vijay-Kumar, M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol. 104, 15.25.1–15.25.14. (2014).

    Article  Google Scholar 

Download references


We thank Dr. H Ueda at RCAST, University of Tokyo for advice for statical analysis and Drs. R Nozu and R Takahashi at CIEA for technical advice for bacterial colonization in ASF mice. We also thank Drs. M Kataoka and H Kobayashi at National Institute of Infectious Diseases for technical assistance for electron microscope. This work was supported in part by Grant-In-Aid for Scientific Research (S) 15638461 and (C) 18K07166 from the Ministry of Education, Culture, Sports, Science (MEXT), Japan Agency for Medical Research and Development (A-MED) 15656877, Takeda Science foundation, The Nakajima Foundation, The Sumitomo Foundation, and Terumo Life Science Foundation. S.M. is a research fellow of the Japan Society for the Promotion of Science. The Department of Molecular Immunology is supported by Kyowa Hakko Kirin Co., Ltd.

Author information




J.N., H.N., M.Y., S.M., S.H. and H.Y. performed experiments and prepared Figs. 1a, 2, 3 and 4, Supplemental Tables S2 and S4, and Supplemental Figs. S1, S2S3, S6, S7, S8, S10 and S11. K.M. and Y.T. performed experiments and prepared Fig. 1a, c, e–g and Supplemental Table S1. T.M. and M.U. performed experiments and prepared Figs. 3 and 4 and Supplemental Fig. S7. K.A. and Y.I. prepared Supplemental Table S2 and Figs. S4 and S5. A.A. and H.H. performed experiments and prepared Fig. 1c, d. M.M. prepared Supplemental Table S3 and Fig. S9. J.N. and T.T. wrote main manuscript. All authors reviewed the manuscript.

Corresponding author

Correspondence to Tadatsugu Taniguchi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nishio, J., Negishi, H., Yasui-Kato, M. et al. Identification and characterization of a novel Enterococcus bacteriophage with potential to ameliorate murine colitis. Sci Rep 11, 20231 (2021).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links